Drug Repurposing: Far Beyond New Targets for Old Drugs

Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 4

Abstract

Repurposing drugs requires finding novel therapeutic indications compared to the ones for which they were already approved. This is an increasingly utilized strategy for finding novel medicines, one that capitalizes on previous investments while derisking clinical activities. This approach is of interest primarily because we continue to face significant gaps in the drug–target interactions matrix and to accumulate safety and efficacy data during clinical studies. Collecting and making publicly available as much data as possible on the target profile of drugs offer opportunities for drug repurposing, but may limit the commercial applications by patent applications. Certain clinical applications may be more feasible for repurposing than others because of marked differences in side effect tolerance. Other factors that ought to be considered when assessing drug repurposing opportunities include relevance to the disease in question and the intellectual property landscape. These activities go far beyond the identification of new targets for old drugs.

Authors and Affiliations

T. I. Oprea, J. Mestres

Keywords

Related Articles

Physiologically Based Pharmacokinetic Models in the Prediction of Oral Drug Exposure Over the Entire Pediatric Age Range—Sotalol as a Model Drug

In recent years, the increased interest in pediatric research has enforced the role of physiologically based pharmacokinetic (PBPK) models in pediatric drug development. However, an existing lack of published examples co...

Developmental toxicity of prenatal exposure to toluene

Organic solvents have become ubiquitous in our environment and are essential for industry. Many women of reproductive age are incresingly exposed to solvents such as toluene in occupational settings (ie, long-term, lowco...

Application of Method Suitability for Drug Permeability Classification

Experimental models of permeability in animals, excised tissues, cell monolayers, and artificial membranes are important during drug discovery and development as permeability is one of several factors affecting the intes...

Vaccinomics: Current Findings, Challenges and Novel Approaches for Vaccine Development

Recent years have witnessed a growing interest in a field of vaccinology that we have named vaccinomics. The overall idea behind vaccinomics is to identify genetic and other mechanisms and pathways that determine immune...

A Kinetic Degradation Study of Curcumin in Its Free Form and Loaded in Polymeric Micelles

The online version of this article (doi:10.1208/s12248-015-9863-0) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP681283
  • DOI  10.1208/s12248-012-9390-1
  • Views 65
  • Downloads 0

How To Cite

T. I. Oprea, J. Mestres (2012). Drug Repurposing: Far Beyond New Targets for Old Drugs. The AAPS Journal, 14(4), -. https://www.europub.co.uk/articles/-A-681283